SEARCH

SEARCH BY CITATION

References

  • 1
    Eddy AA, Symons JM. Nephrotic syndrome in childhood. Lancet. 2003; 362: 629639.
  • 2
    Lilova MI, Velkovski IG, Topalov IB. Thromboembolic complications in children with nephrotic syndrome in Bulgaria (1974–1996). Pediatr Nephrol. 2000; 15(1–2): 7478.
  • 3
    Cattaneo M. Hyperhomocysteinemia, atherosclerosis and thrombosis. Thromb Haemost. 1999; 81: 16576.
  • 4
    Lechner BL, Bockenauer D, Iragorri S, Kennedy TL, Siegel NJ. The risk of cardiovascular disease in adults with nephrotic syndrome. Pediatr Nephrol. 2004; 19: 744748.
  • 5
    Cattaneo M. Hyperhomocysteinemia, atherosclerosis and thrombosis. Thromb Haemost. 1999; 81: 16576.
  • 6
    Kniazewska MH, Obuchowicz AK, Wielkoszynski T, Zmudzińska-Kitczak J, Urban K, Marek M, Witanowska J, Sieroń-Stołtny K. Atherosclerosis risk factors in young patients formerly treated for idiopathic nephrotic syndrome. Pediatr Nephrol. 2009; 24: 549554.
  • 7
    Li N, Chen YF, Zou AP. Implications of hyperhomocysteinemia in glomerular sclerosis in hypertension. Hypertension. 2002; 39: 443448.
  • 8
    Podda GM, Lussana F, Moroni G, Faioni MF, Lombardi R, Fontana G, Ponticelli C, Maili C, Cattaneo M. Abnormalities of homocysteine and B vitamins in the nephrotic syndrome. Thromb Res.. 2007; 120: 647652.
  • 9
    Joven J, Arcelus R, Camps J, Ordonez Lianos J, Vilella E, Gonzalez-Sastre F, Blanco-Vaca F. Determinants of plasma homocysteine in patients with nephrotic syndrome. J Mol Med. 2000; 78: 14754.
  • 10
    Arnadottir M, Hultberg B, Berg AL. Plasma total homocysteine concentration in nephrotic patients with idiopathic membranous nephropathy. Nephrol Dial Transplant. 2001; 16: 457.
  • 11
    Dogra G, Irish AB, Watts GF. Homocysteine and nephrotic syndrome. Nephrol Dial Transplant. 2001; 16: 17201.
  • 12
    Indian Pediatric Nephrology Group. Indian Academy of Pediatrics. Management of steroid sensitive nephrotic syndrome: revised guidelines. Indian Pediatrics. 2008; 45: 203214.
  • 13
    Refsum H, Helland S, Ueland PM. Radioenzymatic determination of homocysteine in plasma and urine. ClinChem. 1985; 31: 6248.
  • 14
    Araki A, Sako Y. Detarmination of free and total homocysteine in human plasma by high-performance liquid chromatography with fluorescence detection. J Chromatogr. 1987;422: 4352.
  • 15
    Refsum H, Ueland PM, Svardal AM. Fully automated fluorescence assay for determination of total homocysteine in plasma. Clin Chem. 1989; 35: 19217.
  • 16
    Jacobsen DW, Gatautis VJ, Green R. Determination of plasma homocysteine by high-performance liquid chromatography with fluorescence detection. Anal Biochem. 1989; 178: 20814.
  • 17
    Newton GL, Dorian R, Fahey RC. Analysis of biological thiols: derivitization with mono-bromo-bimaneaand separation by reverse phase high-performance liquid chromatography. Anal Biochem. 1987; 114: 38387.
  • 18
    Rothenberg SP. Assay of serum vitamin B12 concentration using Co57-B12 and intrinsic factor. Proc Soc Exp Biol Med. 1961; 108: 4548.
  • 19
    Gutcho S, Mansbach L. Simultaneous radioassay of serum vitamin B12 and folic acid. Clin Chem. 1977; 23: 16091614.
  • 20
    Rothenberg SP, DaCostaMRosenberg BS. A radioassay for serum folate: use of two phase sequential incubation, ligand binding system. New Eng J Med. 1972; 285(25): 133539.
  • 21
    Tkaczyk M, Czupryniak A, Nowicki M, Chwatko G, Bald E. Homocysteine and glutathione metabolism in steroid treated relapse of idiopathic nephrotic syndrome. Pol Merkur Lekarski. 2009; 26: 2947.
  • 22
    Chambers JC, Ueland PM, Obeid OA, Wrigley J, Refsum H, Konner JS. Improved vascular endothelial function after oral B vitamins: an effect mediated through reduced concentrations of free plasma homocysteine. Circulation. 2000; 102: 247983.
  • 23
    Ozkan Y, Ozkan E, Simşek B. Plasma total homocysteine and cysteine levels as cardiovascular risk factors in coronary heart disease. Int J Cardiol. 2002; 82(3): 26977.
  • 24
    Tenderenda E, Korzeniecka-Kozerska A, Porowski T, Wasilewska A, Zoch-Zwierz W. Serum and urinary homocysteine in children with steroid-dependent nephrotic syndrome. Pol Merkur Lekarski. 2011 Oct; 31(184): 2048.
  • 25
    Chen YF, Li PL, Zou AP. Effect of hyperhomocysteinemia on plasma or tissue adenosine levels and renal function. Circulation. 2002; 106: 12751281.
  • 26
    Cramer DV, Wu GD, Chapman FA, Marboe C, Salomon DR. 2-Chlorodeoxyadenosine in combination with cyclosporine inhibits the development of transplant arteriosclerosis in rat cardiac allografts. Transplant Proc. 1997; 29: 616.